Literature DB >> 22402019

Imaging-based assessment of the mineral composition of urinary stones: an in vitro study of the combination of hounsfield unit measurement in noncontrast helical computerized tomography and the twinkling artifact in color Doppler ultrasound.

Hakim Hassani1, Gauthier Raynal, Romain Spie, Michel Daudon, Jean-Noël Vallée.   

Abstract

We evaluated the value of combining noncontrast helical computerized tomography (NCHCT) and color Doppler ultrasound in the assessment of the composition of urinary stones. In vitro, we studied 120 stones of known composition, that separate into the five main types: 18 calcium oxalate monohydrate (COM) stones, 41 calcium oxalate dihydrate (COD) stones, 24 uric acid stones, 25 calcium phosphate stones and 12 cystine calculi. Stones were characterized in terms of their Hounsfield density (HU) in NCHCT and the presence of a twinkling artifact (TA) in color Doppler ultrasound. There were statistically significant HU differences between calcium and non-calcium stones (p < 0.001), calcium oxalate stones and calcium phosphate stones (p < 0.001) and uric acid stones and cystine calculi (p < 0.001) but not between COM and COD stones (p = 0.786). Hence, the HU was a predictive factor of the composition of all types of stones, other than for COM and COD stones within the calcium oxalate class (p > 0.05). We found that the TA does not enable differentiation between calcium and non-calcium stones (p > 0.999), calcium oxalate stones and calcium phosphate stones (p = 0.15), or uric acid stones and cystine calculi (p = 0.079). However, it did reveal a significant difference between COM and COD stones (p = 0.002). The absence of a TA is a predictive factor for the presence of COM stones (p = 0.008). Hence, the association of NCHCT and Doppler enables the accurate classification of the five types of stones in vitro.
Copyright © 2012 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22402019     DOI: 10.1016/j.ultrasmedbio.2012.01.009

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  6 in total

1.  Can Doppler ultrasonography twinkling artifact be used as an alternative imaging modality to non-contrast-enhanced computed tomography in patients with ureteral stones? A prospective clinical study.

Authors:  Volkan Sen; Cetin Imamoglu; Ibrahim Kucukturkmen; Tansu Degirmenci; Ibrahim Halil Bozkurt; Tarik Yonguc; Ozgu Aydogdu; Bulent Gunlusoy
Journal:  Urolithiasis       Date:  2016-05-12       Impact factor: 3.436

2.  The use of non-contrast computed tomography and color Doppler ultrasound in the characterization of urinary stones - preliminary results.

Authors:  Mesut Bulakçı; Tzevat Tefik; Fatih Akbulut; Mehmet Tolgahan Örmeci; Caner Beşe; Öner Şanlı; Tayfun Oktar; Artür Salmaslıoğlu
Journal:  Turk J Urol       Date:  2015-12

3.  Acoustic shadowing in pediatric kidney stone ultrasound: a retrospective study with non-enhanced computed tomography as reference standard.

Authors:  Martijn V Verhagen; Tom A Watson; Melissa Hickson; Naima Smeulders; Paul D Humphries
Journal:  Pediatr Radiol       Date:  2019-03-14

4.  B-mode ultrasound versus color Doppler twinkling artifact in detecting kidney stones.

Authors:  Mathew D Sorensen; Jonathan D Harper; Ryan S Hsi; Anup R Shah; Manjiri K Dighe; Stephen J Carter; Mariam Moshiri; Marla Paun; Wei Lu; Michael R Bailey
Journal:  J Endourol       Date:  2013-01-30       Impact factor: 2.942

Review 5.  How can and should we optimize extracorporeal shockwave lithotripsy?

Authors:  Christian G Chaussy; Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2017-11-25       Impact factor: 3.436

6.  An investigation into the clinical accuracy of twinkling artifacts in patients with urolithiasis smaller than 5 mm in comparison with computed tomography scanning.

Authors:  Mohammad Qasem Hanafi; Ahmad Fakhrizadeh; Esmat Jaafaezadeh
Journal:  J Family Med Prim Care       Date:  2019-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.